Neurothera Labs Inc.
NTLX.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -- | 664.10% | 1,353.85% | -- | |
| Total Receivables | -- | -- | 71.11% | -- | |
| Inventory | -- | -- | -33.63% | -- | |
| Prepaid Expenses | -- | -- | -- | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | 0.00% | -- | |
| Total Current Assets | -- | -- | 553.68% | -- | |
|
|
|||||
| Total Current Assets | -- | -- | 553.68% | -- | |
| Net Property, Plant & Equipment | -- | -- | -- | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -20.89% | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | -- | -- | -- | -- | |
| Total Assets | -- | -- | 71.94% | -- | |
|
|
|||||
| Total Accounts Payable | -- | -- | 2,206.67% | -- | |
| Total Accrued Expenses | -- | -- | 75.66% | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Liabilities | -- | -- | 1,463.64% | -- | |
| Total Other Current Liabilities | -- | -- | 1,463.64% | -- | |
| Total Current Liabilities | -- | -- | 509.73% | -- | |
|
|
|||||
| Total Current Liabilities | -- | -- | 509.73% | -- | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | 955.31% | -- | |
|
|
|||||
| Common Stock & APIC | -- | -- | 351.16% | -- | |
| Retained Earnings | -- | -- | -19.78% | -- | |
| Treasury Stock & Other | -- | -- | -- | -- | |
| Total Common Equity | -- | 297.96% | -82.91% | -- | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
|
|
|||||
| Total Common Equity | -- | 297.96% | -82.91% | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
| Total Minority Interest | -- | -- | -31.83% | -- | |
| Total Equity | -- | 381.60% | -57.87% | -- | |
|
|
|||||